Accepting new patients

Dr. Karen Hunt, MD

Hematology ·  Female · Age 63

Dr. Hunt

Northwest Oncology & Hematology

350 Heritage Way Ste 1100 Kalispell, MT 59901

Accepting new patients

Make an Appointment

(406) 752-8900


Dr. Karen Hunt, MD is a hematology specialist in Kalispell, MT and has been practicing for 31 years. She graduated from Northwestern U, School Of Medicine in 1982 and specializes in hematology.


At a glance

  • Explains conditions well . Patients said this doctor explains conditions well. See reviews
  • Hospital satisfaction . Patients said they were highly satisfied at this doctor's hospital. See hospitals
  • Good patient care . Patients said they had exceptional care at this hospital. See hospitals

Insurance Check

Search for your insurance provider

Dr. Hunt accepts

Accepted insurance can change. Please double-check when making an appointment.

(406) 752-8900

Dr. Hunt accepts the following insurance:

Aetna
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna PPO
Open Access Plus
MultiPlan
MultiPlan PPO

Background Check

Healthgrades does not collect malpractice claims information for Montana
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Hunt's experience treating your condition or procedure

Dr. Hunt's Top Procedures and Conditions

Treatment Frequency
Breast Diseases
very high
very high

Treatment Frequency

Dr. Hunt treats Breast Diseases more than 93% of her peers

Dr. Hunt treats this condition more than 93% of her peers

Cancer
high
high

Treatment Frequency

Dr. Hunt treats Cancer more than 81% of her peers

Dr. Hunt treats this condition more than 81% of her peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Secondary Malignancies
normal
normal

Treatment Frequency

Dr. Hunt treats Secondary Malignancies more than 66% of her peers

Dr. Hunt treats this condition more than 66% of her peers

Dr. Hunt's conditions and procedures:

  • Acute Leukemia
  • Acute Myeloid Leukemia
  • Adrenal Gland Cancer
  • All Lymphoma
  • Anal and Rectal Cancer
  • Anal Disorders
  • Anemia
  • Aortic Embolism and Thrombosis
  • Autoimmune Diseases
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Bleeding Disorders
  • Blood Disorders
  • Bone Cancer
  • Bone Disorders
  • Bone Marrow Biopsy
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brain Disorders
  • Breast Cancer
  • Breast Diseases
  • Burkitt's Lymphoma
  • Cancer
  • Central Nervous System Lymphoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Disorders (incl. Hemophilia)
  • Colorectal Cancer
  • Cryoglobulinemia
  • Deep Vein Thrombosis (DVT)
  • Esophageal Cancer
  • Esophageal Diseases
  • Fallopian Tube Cancer
  • Gallbladder and Biliary Tract Cancer
  • Gastrointestinal Diseases
  • Graft vs Host Disease
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Kidney Cancer
  • Larynx Conditions
  • Leukocytosis
  • Liver Cancer
  • Lung Cancer
  • Lung Neoplasms, Not Specified as Malignant
  • Lymphocytosis
  • Lymphoma, Large Cell, Anaplastic
  • Lymphoma, Large-Cell
  • Macroglobulinemia (incl. Waldenstrom's )
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Mediastinal Tumors, Malignant
  • Melanoma
  • Meningiomas
  • Merkel Cell Carcinoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders
  • Neuroendocrine Tumors
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Oral Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pancytopenia
  • Pleura Cancer
  • Pleural Cancer
  • Polycythemia Rubra Vera
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Prostate Cancer
  • Pulmonary Disease
  • Purpura
  • Qualitative Platelet Defects (incl. Glanzmann's Thrombasthenia)
  • Reticulosarcoma
  • Secondary Malignancies
  • Skin Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Carcinoma
  • Stomach and Small Intestine Cancer
  • Stomach Diseases
  • Testicular Cancer
  • Thalassemia
  • Thoracentesis
  • Thrombocytosis
  • Thrombosis
  • Thymomas
  • Thyroid Cancer
  • Tongue Cancer
  • Urinary Disorders
  • Uterine Cancer
  • Uterine Diseases
  • Vascular Disease
  • Venous Embolism and Thrombosis
  • Vertebral Column Tumors
  • von Willebrand Disease

Dr. Hunt's Reviews

Likelihood to recommend Dr. Hunt

5.0

Based on 4 reviews

5 Stars
100%
(4)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Hunt?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Hunt's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness

Be the first to leave a comment

How was your experience with Dr. Hunt?

About Me

Biography

Dr. Karen Hunt, MD is a hematology specialist in Kalispell, MT and has been practicing for 31 years. She graduated from Northwestern U, School Of Medicine in 1982 and specializes in hematology.

Specialties

  • Hematology

Board Certifications

  • Hematology
  • Internal Medicine
  • Medical Oncology

Education

1988
University Of Washington
Fellowship Hospital
1985
University Of Iowa Hospitals & Clinics
Residency Hospital
1983
University Of Iowa Hospitals & Clinics
Internship Hospital
1982
Northwestern U, School Of Medicine
Medical School
1988
1985
1983
1982

Awards

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Hunt treats patients.

Learn more

71% Patient experience rating, 2% higher than the national average

75% Patient experience rating, 6% higher than the national average

  • Outstanding Patient Experience Award™ (2019, 2017)

The Healthcenter

Kalispell, MT

76% Patient experience rating, 7% higher than the national average

  • Patient Safety Excellence Award™ (2017)